FAPI PET显像在胰腺癌中的作用:与18F-FDG PET比较的Meta分析
该Meta分析纳入截至2024年1月1日发表的7项研究共322例患者,比较FAPI PET与18F-FDG PET/CT对胰腺癌的诊断效能。FAPI PET的合并敏感度为0.99(95%CI:0.97-1.00),高于18F-FDG的0.84(95%CI:0.70-0.92);AUC为0.99(95%CI:0.98-1.00) vs 0.91(95%CI:0.88-0.93)。FAPI PET在原发肿瘤、淋巴结转移和远处转移的合并敏感度上均优于18F-FDG,并使25%的患者TNM分期得到改善、11.7%的患者临床管理发生改变。
要点
- FAPI PET诊断胰腺癌的合并敏感度为0.99(95%CI:0.97-1.00),高于18F-FDG的0.84(95%CI:0.70-0.92)。
- FAPI PET的AUC为0.99(95%CI:0.98-1.00),18F-FDG为0.91(95%CI:0.88-0.93)。
- FAPI PET使25%的胰腺癌患者TNM分期改善、11.7%的患者临床管理改变。
核心结论
- FAPI PET显像在原发胰腺癌、淋巴结转移和远处转移的检测、TNM分期及临床管理方面均优于18F-FDG。
研究设计与样本
- Meta分析,纳入截至2024年1月1日发表的7项原始研究共322例患者,检索pubmed和web of science,主题词包括胰腺癌和FAPI,采用QUADAS-2评价纳入研究质量,使用R语言进行Meta分析。
诊断标准与关键数值
- FAPI PET与18F-FDG PET/CT比较:合并敏感度0.99(95%CI:0.97-1.00) vs 0.84(95%CI:0.70-0.92),AUC 0.99(95%CI:0.98-1.00) vs 0.91(95%CI:0.88-0.93);FAPI PET在原发肿瘤、淋巴结转移和远处转移的合并敏感度上均优于18F-FDG。
临床应用与阅片要点
- 与18F-FDG相比,FAPI PET使25%的胰腺癌患者TNM分期改善,并使11.7%的患者临床管理发生改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Fibroblast activating protein is a promising target for tumor molecular imaging and therapy. Studies showed that fibroblast activating protein inhibitor (FAPI) radioactive tracers presented superiority over 18F-FDG PET/CT in the evaluation of various cancer types, including pancreatic cancer (PC). Therefore, we conducted this meta-analysis to evaluate and analyze the differences between 68Ga/18F-FAPI and 18F-FDG in PC, in order to provide evidence for the clinical application of FAPI PET imaging.
METHODS: In the current meta-analysis, original studies published as of January 1, 2024 were analyzed using radiolabeled FAPI as a diagnostic radioactive tracer and compared to 18F-FDG for PET in PC. Databases searched included pubmed and web of science, and subject headings searched included PC and FAPI. The quality of the enrolled studies was evaluated by Quality Assessment of Diagnostic Accuracy Studies 2, and the meta-analysis was conducted using R language.
RESULTS: A total of seven studies including 322 patients compared the diagnostic performance of FAPI PET imaging and 18F-FDG PET/CT in PC. Overall, FAPI PET imaging showed higher pooled sensitivity (0.99 [95% CI: 0.97-1.00] vs. 0.84 [95% CI: 0.70-0.92]) and area under the curve (0.99 [95% CI: 0.98-1.00] vs. 0.91 [95% CI: 0.88-0.93]) than 18F-FDG PET/CT. The evidence showed that FAPI PET imaging is superior to 18F-FDG in pooled sensitivity to primary tumor, lymph node metastasis, and distant metastasis. Moreover, FAPI PET imaging improved TNM staging in 25% of PC patients and changed clinical management in 11.7% of PC patients compared to 18F-FDG.
CONCLUSION: FAPI PET imaging is superior to that of 18F-FDG in the detection of primary PC, nodal and distant metastases, TNM staging and clinical management.
引用
- Hu X, Li X, Wang P, et al. The Role of FAPI PET Imaging in Pancreatic Cancer: A Meta-analysis Compared with 18F-FDG PET. Acad Radiol. 2024. PMID: 39097507. doi:10.1016/j.acra.2024.07.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。